Loading...
Help
Login
Busy
Search
Covid-19 Research-Dataset - Datasets
 
Concept locked
Concept locked
Select Target
Select Concept
De-inherit concept

Select object
 
Edit
Filter
Edit
Covid-19-Therapie
Idcovid19f-dataelement-1990Version2020-04-08
StatusDraftVersion Label
Description
Medikamentöse Therapie bei Covid-19 Erkrankung
Value
TypeCode
Value Set Association
requiredTo be conformant, instances of this element SHALL include a code from the specified value set. Medikamentöse Therapie UNII (Dynamic)
extensibleTo be conformant, instances of this element SHALL include a code from the specified value set if any of the codes within the value set can apply to the concept being communicated. If the valueset does not cover the concept (based on human review), an alternate system.code may be used instead. Medikamentöse Therapie OPS (Dynamic)
extensibleTo be conformant, instances of this element SHALL include a code from the specified value set if any of the codes within the value set can apply to the concept being communicated. If the valueset does not cover the concept (based on human review), an alternate system.code may be used instead. Medikamentöse Therapie ATC (Dynamic)
requiredTo be conformant, instances of this element SHALL include a code from the specified value set. Convalescent Plasma (Dynamic)
Concepts
ConceptCodeDisplay NameCodesystem
Antipyretika
N02B
ANDERE ANALGETIKA UND ANTIPYRETIKA
1.2.276.0.76.5.498
Kortikosteroide
R03AL
S02B
R03AK
M01BA
H02
G01B
Sympathomimetika in Kombination mit Anticholinergika inkl. Dreifachkombinationen mit Corticosteroiden
CORTICOSTEROIDE
Sympathomimetika in Kombination mit Corticosteroiden oder anderen Mitteln, exkl. Anticholinergika
Antiphlogistika/Antirheumatika in Kombination mit Corticosteroiden
CORTICOSTEROIDE ZUR SYSTEMISCHEN ANWENDUNG
ANTIINFEKTIVA/ANTISEPTIKA IN KOMBINATION MIT CORTICOSTEROIDEN
1.2.276.0.76.5.498
1.2.276.0.76.5.498
1.2.276.0.76.5.498
1.2.276.0.76.5.498
1.2.276.0.76.5.498
1.2.276.0.76.5.498
Atazanavir
J05AR23
J05AR15
J05AE08
Atazanavir und Ritonavir
Atazanavir und Cobicistat
Atazanavir
1.2.276.0.76.5.498
1.2.276.0.76.5.498
1.2.276.0.76.5.498
Darunavir
J05AR14
J05AE10
J05AR22
Darunavir und Cobicistat
Darunavir
Emtricitabin, Tenofoviralafenamid, Darunavir und Cobicistat
1.2.276.0.76.5.498
1.2.276.0.76.5.498
1.2.276.0.76.5.498
Chloroquine phosphate
P01BA01
Chloroquin
1.2.276.0.76.5.498
Hydroxychloroquine
P01BA02
Hydroxychloroquin
1.2.276.0.76.5.498
Ivermectin
P02CF01
D11AX22
Ivermectin
Ivermectin
1.2.276.0.76.5.498
1.2.276.0.76.5.498
Lopinavir/ritonavir
J05AR10
Lopinavir und Ritonavir
1.2.276.0.76.5.498
Ganciclovir
S01AD09
J05AB06
Ganciclovir
Ganciclovir
1.2.276.0.76.5.498
1.2.276.0.76.5.498
Oseltamivir
J05AH02
Oseltamivir
1.2.276.0.76.5.498
Remdesivir
3QKI37EEHE
Remdesivir
The Unique Ingredient Identifier (UNII) generated from the FDA Substance Registration System (SRS).
Ribavirin
J05AP01
Ribavirin
1.2.276.0.76.5.498
Camostat
B02AB04
Camostat
1.2.276.0.76.5.498
Favipiravir
J05AX27
Favipiravir
1.2.276.0.76.5.498
Convalescent plasma
E9747
E9752
E9750
E9749
E9748
E9743
E9746
E9745
E9744
Apheresis CONVALESCENT PLASMA|ACD-A/XX/<=-18C|COVID-19
Thawed Apheresis CONVALESCENT PLASMA|ACD-A/XX/refg|COVID-19
Liquid Apheresis CONVALESCENT PLASMA|NS/XX/refg|COVID-19
CONVALESCENT PLASMA|NS/XX/Frozen|COVID-19
Apheresis CONVALESCENT PLASMA|NS/XX/Frozen|COVID-19
Apheresis CONVALESCENT PLASMA|NS/XX/<=-25C|COVID-19
Apheresis CONVALESCENT PLASMA|NS/XX/<=-25C|Riboflavin-treated|COVID-19
Apheresis CONVALESCENT PLASMA|NS/XX/<=-25C|Psoralen-treated|COVID-19
Apheresis CONVALESCENT PLASMA|NS/XX/<=-25C|Methylene blue-treated|COVID-19
2.16.840.1.113883.6.18.2.6
2.16.840.1.113883.6.18.2.6
2.16.840.1.113883.6.18.2.6
2.16.840.1.113883.6.18.2.6
2.16.840.1.113883.6.18.2.6
2.16.840.1.113883.6.18.2.6
2.16.840.1.113883.6.18.2.6
2.16.840.1.113883.6.18.2.6
2.16.840.1.113883.6.18.2.6
Steroids (> 0.5 mg/kg prednisone equivalents)
Steroids (<= 0.5 mg/kg prednisone equivalents)
Tocilizumab
6-005.m
6-005.n
L04AC07
Tocilizumab, intravenös
Tocilizumab, subkutan
Tocilizumab
1.2.276.0.76.5.487
1.2.276.0.76.5.487
1.2.276.0.76.5.498
Sarilumab
6-00a.g
L04AC14
Sarilumab, parenteral
Sarilumab
1.2.276.0.76.5.487
1.2.276.0.76.5.498
CNI or mTor inhibitors (e.g. cyclosporin A, tacrolimus, sirolimus, everolimus)
6-005.8
6-004.e
D11AH01
L04AA10
L04AA18
L01XE10
L04AB
L04AD
L01XE18
S01XA18
Everolimus, oral
Temsirolimus, parenteral
Tacrolimus
Sirolimus
Everolimus
Everolimus
Tumornekrosefaktor alpha(TNF-alpha)-Inhibitoren
Calcineurin-Inhibitoren
Ruxolitinib
Ciclosporin
1.2.276.0.76.5.487
1.2.276.0.76.5.487
1.2.276.0.76.5.498
1.2.276.0.76.5.498
1.2.276.0.76.5.498
1.2.276.0.76.5.498
1.2.276.0.76.5.498
1.2.276.0.76.5.498
1.2.276.0.76.5.498
1.2.276.0.76.5.498
Anti-TNF-alpha inhibitors (e.g. adalimumab, etanercept)
6-001.d
6-002.b
6-005.7
6-005.2
6-001.e
Adalimumab, parenteral
Etanercept, parenteral
Certolizumab, parenteral
Golimumab, parenteral
Infliximab, parenteral
1.2.276.0.76.5.487
1.2.276.0.76.5.487
1.2.276.0.76.5.487
1.2.276.0.76.5.487
1.2.276.0.76.5.487
Il1-receptor antangonists
6-006.7
L04AC
Canakinumab, parenteral
Interleukin-Inhibitoren
1.2.276.0.76.5.487
1.2.276.0.76.5.498
Ruxolitinib
6-009.4
Ruxolitinib, oral
1.2.276.0.76.5.487
Colchicine
M04AC01
Colchicin
1.2.276.0.76.5.498
Interferone (any)
S01AD05
Interferon
1.2.276.0.76.5.498
25-Hydroxyvitamin D
A11CC06
Calcifediol
1.2.276.0.76.5.498
Zinc
A12CB
Zink
1.2.276.0.76.5.498
Andere
/
-
/
-
/
/
Usage (0)
Busy
/
Busy
 
 
History (7)
DateAuthorStatusType
2020-06-22 08:29:54Julian SassDraftversion
2020-06-05 11:07:38Julian SassDraftversion
2020-05-22 17:54:46Eugenia RinaldiDraftversion
2020-05-22 17:54:29Eugenia RinaldiDraftversion
2020-05-22 17:52:05Eugenia RinaldiDraftversion
2020-05-06 13:02:33Julian SassDraftversion
2020-05-04 10:27:50Julian SassDraftversion
DatasetCovid-19 Forschungsdatensatz
Id2.16.840.1.113883.3.1937.99.61.65.1.1Version2020-04-08 13:04:13
StatusDraftVersion Label
Usage (1)
Busy
TransactionProject
Initial Covid-19 Forschungsdatensatz
Busy
 
 
History (91)
DateAuthorStatusType
2020-06-02 08:39:12Alexander BartschkeDraftmove
2020-06-02 08:38:44Alexander BartschkeDraftmove/version
2020-06-02 08:38:44Alexander BartschkeDraftmove/version
2020-05-21 12:13:09Julian SassDraftmove
2020-05-21 12:12:06Julian SassDraftmove
2020-05-20 13:44:31Alexander BartschkeDraftmove
2020-05-20 13:44:31Alexander BartschkeDraftmove
2020-05-20 13:44:31Alexander BartschkeDraftmove
2020-05-20 13:44:31Alexander BartschkeDraftmove
2020-05-20 13:44:31Alexander BartschkeDraftmove
2020-05-20 13:44:31Alexander BartschkeDraftmove
2020-05-20 13:44:31Alexander BartschkeDraftmove
2020-05-20 13:44:31Alexander BartschkeDraftmove
2020-05-20 13:44:31Alexander BartschkeDraftmove
2020-05-20 13:44:31Alexander BartschkeDraftmove
2020-05-20 13:44:31Alexander BartschkeDraftmove
2020-05-20 13:44:31Alexander BartschkeDraftmove
2020-05-20 13:44:31Alexander BartschkeDraftmove
2020-05-20 13:44:31Alexander BartschkeDraftmove
2020-05-20 13:44:31Alexander BartschkeDraftmove
2020-05-20 13:44:31Alexander BartschkeDraftmove
2020-05-20 13:44:31Alexander BartschkeDraftmove
2020-05-20 13:44:31Alexander BartschkeDraftmove
2020-05-20 13:44:31Alexander BartschkeDraftmove
2020-05-20 13:44:31Alexander BartschkeDraftmove
2020-05-20 13:44:31Alexander BartschkeDraftmove
2020-05-20 13:42:48Alexander BartschkeDraftmove/version
2020-05-20 13:42:48Alexander BartschkeDraftmove/version
2020-05-20 13:39:24Alexander BartschkeDraftmove
2020-05-20 13:39:24Alexander BartschkeDraftmove
2020-05-20 13:39:24Alexander BartschkeDraftmove
2020-05-20 13:39:24Alexander BartschkeDraftmove
2020-05-20 13:39:24Alexander BartschkeDraftmove
2020-05-20 13:39:24Alexander BartschkeDraftmove
2020-05-20 13:39:24Alexander BartschkeDraftmove
2020-05-20 13:39:24Alexander BartschkeDraftmove
2020-05-20 13:39:24Alexander BartschkeDraftmove
2020-05-20 13:39:24Alexander BartschkeDraftmove
2020-05-20 13:39:24Alexander BartschkeDraftmove
2020-05-20 13:39:24Alexander BartschkeDraftmove
2020-05-20 13:39:24Alexander BartschkeDraftmove
2020-05-20 13:39:24Alexander BartschkeDraftmove
2020-05-20 13:39:24Alexander BartschkeDraftmove
2020-05-20 13:39:24Alexander BartschkeDraftmove
2020-05-20 13:39:24Alexander BartschkeDraftmove
2020-05-20 13:37:09Alexander BartschkeDraftmove/version
2020-05-20 13:37:09Alexander BartschkeDraftmove/version
2020-05-19 10:01:53Julian SassDraftmove/version
2020-05-19 10:01:53Julian SassDraftmove/version
2020-05-19 10:01:27Julian SassDraftmove/version
2020-05-19 10:01:27Julian SassDraftmove/version
2020-05-19 10:00:55Julian SassDraftmove/version
2020-05-19 10:00:55Julian SassDraftmove/version
2020-05-19 10:00:35Julian SassDraftmove/version
2020-05-19 10:00:35Julian SassDraftmove/version
2020-05-19 10:00:14Julian SassDraftmove/version
2020-05-19 10:00:14Julian SassDraftmove/version
2020-05-19 09:57:27Julian SassDraftmove/version
2020-05-19 09:57:27Julian SassDraftmove/version
2020-05-19 09:56:56Julian SassDraftmove/version
2020-05-19 09:56:56Julian SassDraftmove/version
2020-05-19 09:56:39Julian SassDraftmove/version
2020-05-19 09:56:39Julian SassDraftmove/version
2020-05-19 09:56:21Julian SassDraftmove/version
2020-05-19 09:56:21Julian SassDraftmove/version
2020-05-03 23:56:22Julian SassDraftmove
2020-05-03 23:56:22Julian SassDraftmove
2020-05-03 23:35:21Julian SassDraftmove
2020-05-03 23:35:21Julian SassDraftmove
2020-05-03 23:34:37Julian SassDraftmove
2020-05-03 23:34:37Julian SassDraftmove
2020-05-03 23:33:23Julian SassDraftmove
2020-05-03 23:33:23Julian SassDraftmove
2020-05-03 23:30:44Julian SassDraftmove
2020-05-03 23:30:44Julian SassDraftmove
2020-05-03 22:56:35Julian SassDraftmove
2020-05-03 22:56:35Julian SassDraftmove
2020-05-03 16:52:08Julian SassDraftmove
2020-05-03 16:52:08Julian SassDraftmove
2020-05-03 16:49:19Julian SassDraftmove
2020-05-03 16:49:19Julian SassDraftmove
2020-05-03 16:14:20Julian SassDraftmove
2020-05-03 16:14:20Julian SassDraftmove
2020-05-03 14:49:25Julian SassDraftmove
2020-05-03 14:49:25Julian SassDraftmove
2020-04-30 15:34:40Alexander BartschkeDraftmove/version
2020-04-30 15:34:40Alexander BartschkeDraftmove/version
2020-04-30 15:32:35Alexander BartschkeDraftmove/version
2020-04-30 15:32:35Alexander BartschkeDraftmove/version
2020-04-30 13:27:32Julian SassDraftmove
2020-04-30 13:27:32Julian SassDraftmove